Laboratory Test Update
Edition #402 | November 2012
FP Essentials is a monthly subscription containing authoritative, unbiased, and peer-reviewed clinical information -- without any advertisements.
Purchase this individual edition for online access to its content, and earn up to 5 CME credits upon completion of the quiz. Online access for this edition available until November 2014.
In This Edition
- Describe the most common deficiency found by Clinical Laboratory Improvement Amendments inspectors during evaluations of laboratories that perform point-of-care laboratory testing.
- Discuss what outcomes, if any, change when point-of-care laboratory tests of lipids, hemoglobin A1c, and international normalized ratio are used in clinical practice.
- Explain how to use procalcitonin levels in developing a treatment plan for a patient with community-acquired pneumonia.
- Summarize indications for pneumococcal urinary antigen testing in patients with community-acquired pneumonia.
- Cite the correct specimen for Group B Streptococcus screening in women in the third trimester of pregnancy.
- Explain the primary role of cancer biomarkers in the treatment of patients with bladder cancer.
- Identify biomarkers that should be measured in patients with newly diagnosed invasive breast cancer.
- Discuss current recommendations about screening for ovarian cancer in average-risk women.
- Explain how to use soluble transferrin receptor levels for distinguishing iron deficiency anemia from anemia of chronic disease.
- Describe the typical presentation(s) of myelodysplastic syndrome.
Approved for 5 AAFP Prescribed credits; 5 AMA PRA Category 1 credits™. Credit valid through November 30, 2014.
Purchase this Edition
Read It Online
Content accessible after purchase of this edition, FP Essentials Subscription, or FP Essentials + FP Audio Combined Subscription.